Chicago Capital, LLC Procept Bio Robotics Corp Transaction History
Chicago Capital, LLC
- $4.02 Billion
- Q2 2025
A detailed history of Chicago Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 568,972 shares of PRCT stock, worth $33.5 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
568,972
Previous 422,373
34.71%
Holding current value
$33.5 Million
Previous $24.6 Million
33.18%
% of portfolio
0.82%
Previous 0.7%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
303Shares Held
42.1MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$302 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$205 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$126 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$83.4 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$70 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.63B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...